Видео ютуба по тегу Verastem

Exclusive Interview with Dr. Jonathan Pachter, Chief Scientific Officer at Verastem Oncology
Exclusive Interview with Dr. Jonathan Pachter, Chief Scientific Officer at Verastem Oncology
Verastem's Pancreatic Cancer Drug: My Take on the Trial Results
Verastem's Pancreatic Cancer Drug: My Take on the Trial Results
Verastem Oncology | Measurable Results.® | SVA Consulting
Verastem Oncology | Measurable Results.® | SVA Consulting
VSTM Stock Next WEEK CRAZY!? (Exact Play Exposed) Verastem stock best broker review
VSTM Stock Next WEEK CRAZY!? (Exact Play Exposed) Verastem stock best broker review
Verastem, Inc. (VSTM)🔻 анализ акций, тикер: VSTM оценка GURU.Markets​ 📉
Verastem, Inc. (VSTM)🔻 анализ акций, тикер: VSTM оценка GURU.Markets​ 📉
$VSTM: Прорыв Verastem KRAS: шумиха вокруг выкупа и потенциал сжатия 🚀
$VSTM: Прорыв Verastem KRAS: шумиха вокруг выкупа и потенциал сжатия 🚀
VSTM Verastem Oncology: After RAMP 203 Halt - 5 Stock Price Scenarios + Tuesday Predicted Open? 🔥
VSTM Verastem Oncology: After RAMP 203 Halt - 5 Stock Price Scenarios + Tuesday Predicted Open? 🔥
Verastem, Inc. VSTM, отчет о прибылях и убытках за третий квартал 2025 г.
Verastem, Inc. VSTM, отчет о прибылях и убытках за третий квартал 2025 г.
Verastem, vstm stock analysis buy or sell
Verastem, vstm stock analysis buy or sell
Verastem Update 10/4/2022
Verastem Update 10/4/2022
Verastem, vstm stock analysis buy or sell it
Verastem, vstm stock analysis buy or sell it
Verastem's Big Raise: My Take on Their Growth Play
Verastem's Big Raise: My Take on Their Growth Play
VSTM Verastem: Analysts See 68% Surge - 5 Stock Signals & Price Targets Revealed! 🚀
VSTM Verastem: Analysts See 68% Surge - 5 Stock Signals & Price Targets Revealed! 🚀
Verastem Inc, VSTM STOCK ANALYSIS BUY OR SELL
Verastem Inc, VSTM STOCK ANALYSIS BUY OR SELL
VSTM Stock: Dips on EPS Miss & Promising Preliminary Trial Results
VSTM Stock: Dips on EPS Miss & Promising Preliminary Trial Results
Verastem | Precision Oncology Stock. Key Support! | ($VSTM)
Verastem | Precision Oncology Stock. Key Support! | ($VSTM)
Verastem's $75M Bet: Decoding the SEC Filing & Cancer Drug Push
Verastem's $75M Bet: Decoding the SEC Filing & Cancer Drug Push
Verastem VSTM: презентация финансовых результатов за второй квартал 2025 г.
Verastem VSTM: презентация финансовых результатов за второй квартал 2025 г.